1997年4月
Investigation of the mineralocorticoid and hypertensinogenic activity of 18-hydroxycortisol in conscious sheep
STEROIDS
- ,
- ,
- ,
- ,
- ,
- ,
- 巻
- 62
- 号
- 4
- 開始ページ
- 351
- 終了ページ
- 357
- 記述言語
- 英語
- 掲載種別
- DOI
- 10.1016/S0039-128X(96)00245-0
- 出版者・発行元
- ELSEVIER SCIENCE INC
The increased urinary excretion of 18-hydroxycortisol (18-OHF) in patients with primary aldosteronism has raised the possibility that 18-OHF is involved in the maintenance and/or pathogenesis of the associated hypertension. This study has investigated the mineralocorticoid, glucocorticoid, and hypertensinogenic activities of 18-OHF in the conscious sheep. infusion of 18-OHF (400 mu g/h i.v. 5 days; n = 5) alone had no effect on blood pressure or on fluid and electrolyte balance. Infusion of a combination of five adrenal steroids (aldosterone 3 mu g/h, cortisol 5 mg/h, corticosterone 0.5 mg/h, 11-deoxycortisol I mg/h and deoxycorticosterone 25 mu g/h, i.v. 5 days; n = 5) increased blood pressure by 14 +/- 1 mmHg (p < .001), but when 18-OHF was infused together with the five adrenal steroids, no additional increase in blood pressure was observed. In another group of sheep (n = 4) 18-OHF was infused at a range of doses (5, 50, 100, 200, 500, and 1000 mu g/h i.v.), each for 2 h, into sodium-replete and sodium-deplete, adrenalectomized sheep. 18-OHF had no effect on the urinary sodium or potassium excretion or on the salivary Na/K ratio in either group, as compared with vehicle infusion. To examine the renal effects of 18-OHF, a range of doses of 18-OHF (5, 50, 100, 200, 500, and 1000 mu g/h) were infused directly into the renal artery of conscious sheep (n = 4). 18-OHF did not affect the renal blood flow nor the urinary sodium or potassium excretion compared with vehicle infusion. In summary, we could not demonstrate any mineralocorticoid, glucocorticoid, or hypertensinogenic effects of 18-OHF in conscious sheep at a dose of 400 mu g/h. Thus, a cautious approach to interpreting the role that 18-OHF plays in the clinical manifestations of primary aldosteronism, is necessary. (C) 1997 by Elsevier Science Inc.
- リンク情報
-
- DOI
- https://doi.org/10.1016/S0039-128X(96)00245-0
- CiNii Articles
- http://ci.nii.ac.jp/naid/80009523564
- PubMed
- https://www.ncbi.nlm.nih.gov/pubmed/9090795
- Web of Science
- https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:A1997WQ08300003&DestApp=WOS_CPL
- ID情報
-
- DOI : 10.1016/S0039-128X(96)00245-0
- ISSN : 0039-128X
- CiNii Articles ID : 80009523564
- PubMed ID : 9090795
- Web of Science ID : WOS:A1997WQ08300003